EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics

Dongyu Liu iD, Yaping Chen iD

Journal of Cellular and Molecular Medicine · 2024-02 · 28 (3)

DOI: 10.1111/jcmm.18103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 12.01.2024. Verfasst von Dongyu Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Heilongjiang Bayi Agricultural University, Daqing, China. Hauptthemen laut MEDLINE: Porcine respiratory and reproductive syndrome virus, Porcine Reproductive and Respiratory Syndrome, Vaccines. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Postdoctoral project, Heilongjiang Bayi Agricultural University, academic success, introduction of talents scientific research start-up plan project, Heilongjiang Bayi Agricultural University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine reproductive and respiratory syndrome (PRRS) is a respiratory disease in pigs that causes severe economic losses. Currently, live PRRSV vaccines are commonly used but fail to prevent PRRS outbreaks and reinfection. Inactivated PRRSV vaccines have poor immunogenicity, making PRRSV a significant threat to swine health globally. Therefore, there is an urgent need to develop an effective PRRSV vaccine. This study used immunoinformatics to predict, screen, design and construct a candidate vaccine that fused B‐cell epitopes, CTL‐ and HTL‐dominant protective epitopes of PRRSV strain's GP3 and GP5 proteins. The study identified 12 B‐cell epitopes, 6 CTL epitopes and 5 HTL epitopes of GP3 and GP5 proteins. The candidate vaccine was constructed with 50S ribosomal protein L7/L1 molecular adjuvant, which has antigenicity, solubility, stability, non‐allergenicity and a high affinity for its target receptor, TLR‐3. The C‐ImmSim immunostimulation results showed significant increases in cellular and humoral responses (B cells and T cells) and production of TGF‐β, IL‐2, IL‐10, IFN‐γ and IL‐12. The constructed vaccine was stable and immunogenic, and it can effectively induce strong T‐cell and B‐cell immune responses against PRRSV. Therefore, it is a promising candidate vaccine for controlling and preventing PRRSV outbreaks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porcine respiratory and reproductive syndrome virusPorcine Reproductive and Respiratory SyndromeVaccinesAnimalsSwineEpitopes, B-LymphocyteImmunoinformaticsAntibodies, Viral

Stichwörter der Autor:innen

GP3GP5immunoinformaticsporcine reproductive and respiratory syndrome virusvaccine candidate

Substanzen

Epitopes, B-LymphocyteAntibodies, ViralVaccines

Autor:innen und Institutionen

  • Heilongjiang Bayi Agricultural University, Daqing, China.

ORCID-Profile: Dongyu Liu, Yaping Chen

Förderung

  • Heilongjiang Postdoctoral project
  • Heilongjiang Bayi Agricultural University, academic success, introduction of talents scientific research start-up plan project
  • Heilongjiang Bayi Agricultural University

Zitieren

APA

Liu, D., & Chen, Y. (2024). Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics. Journal of Cellular and Molecular Medicine, 28(3). https://doi.org/10.1111/jcmm.18103

Vancouver

Liu D, Chen Y. Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics. Journal of Cellular and Molecular Medicine. 2024;28(3). doi:10.1111/jcmm.18103

BibTeX
@article{Liu2024,
  author = {Liu, Dongyu and Chen, Yaping},
  title = {Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  volume = {28},
  number = {3},
  doi = {10.1111/jcmm.18103}
}
Kostenlos starten →